EGFR T790M Not Yet Recruiting Phase 2 Trials for Osimertinib (DB09330)

IndicationStatusPhase
DBCOND0025017 (EGFR T790M)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs